These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15701774)

  • 1. Improvement of dry mouth by replacing paroxetine with fluvoxamine.
    Arima Y; Kubo C; Tsujimoto M; Ohtani H; Sawada Y
    Ann Pharmacother; 2005 Mar; 39(3):567-71. PubMed ID: 15701774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
    Hori H; Yoshimura R; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
    World J Biol Psychiatry; 2009; 10(4 Pt 2):620-2. PubMed ID: 18609433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.
    Kiev A; Feiger A
    J Clin Psychiatry; 1997 Apr; 58(4):146-52. PubMed ID: 9164424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors.
    Serretti A; Zanardi R; Cusin C; Rossini D; Lilli R; Lorenzi C; Lattuada E; Smeraldi E
    Psychiatry Res; 2001 Nov; 104(3):195-203. PubMed ID: 11728608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.
    Morishita S; Arita S
    Eur Psychiatry; 2003 Dec; 18(8):418-20. PubMed ID: 14680720
    [No Abstract]   [Full Text] [Related]  

  • 6. High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography.
    Suhara T; Takano A; Sudo Y; Ichimiya T; Inoue M; Yasuno F; Ikoma Y; Okubo Y
    Arch Gen Psychiatry; 2003 Apr; 60(4):386-91. PubMed ID: 12695316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Painful palate and xerostomia after using paroxetine].
    Bots CP; van Nieuw Amerongen A; Brand HS
    Ned Tijdschr Tandheelkd; 2008 May; 115(5):271-3. PubMed ID: 18543695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
    Grimsley SR; Jann MW
    Clin Pharm; 1992 Nov; 11(11):930-57. PubMed ID: 1464219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The transfer of selective serotonin reuptake inhibitors to human milk].
    Nordeng H; Bergsholm YK; Bøhler E; Spigset O
    Tidsskr Nor Laegeforen; 2001 Jan; 121(2):199-203. PubMed ID: 11475200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury.
    Satoh K; Takano S; Onogi T; Ohtsuki K; Kobayashi T
    Fukushima J Med Sci; 2006 Jun; 52(1):29-33. PubMed ID: 16995352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative prediction of fetal plasma concentration of fluvoxamine during dosage-tapering to the mother.
    Matsuoka S; Hori S; Satoh H; Nagamatsu T; Fujii T; Sawada Y
    Placenta; 2017 Oct; 58():74-81. PubMed ID: 28962699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
    Mandrioli R; Mercolini L; Saracino MA; Raggi MA
    Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.
    Kato M; Ikenaga Y; Wakeno M; Okugawa G; Nobuhara K; Fukuda T; Fukuda K; Azuma J; Kinoshita T
    Int Clin Psychopharmacol; 2005 May; 20(3):151-6. PubMed ID: 15812265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed recurrent SIADH associated with SSRIs.
    Arinzon ZH; Lehman YA; Fidelman ZG; Krasnyansky II
    Ann Pharmacother; 2002; 36(7-8):1175-7. PubMed ID: 12086550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal.
    Silvestri R; Pace-Schott EF; Gersh T; Stickgold R; Salzman C; Hobson JA
    J Clin Psychiatry; 2001 Aug; 62(8):642-52. PubMed ID: 11561938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.
    Wetzel H; Anghelescu I; Szegedi A; Wiesner J; Weigmann H; Härter S; Hiemke C
    J Clin Psychopharmacol; 1998 Feb; 18(1):2-9. PubMed ID: 9472836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
    Montejo-González AL; Llorca G; Izquierdo JA; Ledesma A; Bousoño M; Calcedo A; Carrasco JL; Ciudad J; Daniel E; De la Gandara J; Derecho J; Franco M; Gomez MJ; Macias JA; Martin T; Perez V; Sanchez JM; Sanchez S; Vicens E
    J Sex Marital Ther; 1997; 23(3):176-94. PubMed ID: 9292833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy.
    Hudd TR; Blake CS; Rimola-Dejesus Y; Nguyen TT; Zaiken K
    J Pharm Pract; 2020 Apr; 33(2):206-212. PubMed ID: 31030620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piloerection induced by replacing fluvoxamine with milnacipran.
    Hori S; Matsuo N; Yamamoto A; Hazui T; Yagi H; Nakano M; Suzuki Y; Miki A; Ohtani H; Sawada Y
    Br J Clin Pharmacol; 2007 Jun; 63(6):665-71. PubMed ID: 17324248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine.
    Azuma J; Hasunuma T; Kubo M; Miyatake M; Koue T; Higashi K; Fujiwara T; Kitahara S; Katano T; Hara S
    Eur J Clin Pharmacol; 2012 Jan; 68(1):29-37. PubMed ID: 21739267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.